- Home
- AKA vs ONCY Comparison
AKA vs ONCY Comparison
Compare AKA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | ONCY |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 107.3M |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | AKA | ONCY |
|---|---|---|
| Price | $10.78 | $0.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $24.33 | $7.33 |
| AVG Volume (30 Days) | 2.1K | ★ 1.5M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | N/A |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $4.89 | $2,505.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.44 | N/A |
| 52 Week Low | $8.42 | $0.77 |
| 52 Week High | $16.38 | $1.51 |
Technical Indicators
Market Signals| Indicator | AKA | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.88 |
| Support Level | N/A | $0.81 |
| Resistance Level | N/A | $1.06 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 15.05 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.